COVID-19 Update: Due to high call volumes, patients may now call or email us for general and/or nurse questions, appointment requests and more.

Bienville Orthopaedic Specialist, Dr. Henry Leis, performs first implantation of the FDA-cleared Ensemble CMC, the first implant in a product line of minimally invasive joint replacements for the hand and wrist.

Mississippi Gulf Coast— Bienville Orthopaedic Specialists is proud to announce that Dr. Henry T. Leis, a board certified, fellowship-trained orthopaedic hand specialist was the first to perform a minimally invasive implantation surgery with Ensemble Orthopedics’s CMC implant for osteoarthritis of the carpometacarpal (CMC) joint.

The FDA-cleared Ensemble CMC was designed to expand the treatment options for patients with osteoarthritis of the carpometacarpal (CMC) joint.  The innovative implant conforms to the anatomy of the natural joint so that bone on bone contact is eliminated, relieving pain while allowing normal motion. By using a minimally invasive surgical procedure, it offers the potential for a reduced recovery time.

“We are proud to be the first center to implant the Ensemble CMC,” said Dr. Leis.  “This technology provides a promising alternative to the more invasive procedures that are available to treat osteoarthritis of the CMC.  We are excited to be able to offer our patients this new solution.”

Bienville Orthopaedics is the largest orthopaedic group in Mississippi and has offices in Gulfport, Biloxi, Gautier, Pascagoula, and Hurley.  For more information, please call (228) 230-2663 or visit www.BienvilleOrtho.com.

Ensemble Orthopedics, a medical device company based in Austin, TX, develops proprietary, interpositional implants designed to employ minimally invasive surgical techniques for the treatment of arthritis in the hand and wrist.  For more information, please visit www.ensembleortho.com.

SOURCE: Ensemble Orthopedics, Inc.

Scroll to Top